Submit Deal

PUREOS BIOVENTURES

HQ - Pfaffikon

Summary

Pureos Bioventures is a venture capital firm that invests in private innovative drug development companies, particularly those focused on the next generation of biological drugs and drug formats.

Deals Overview

Total Deals9

Valued Deals8

Total Value£ 606 M

Avg. Deal Size£ 76 M

Market Context

Senior Management

Christian Altorfer
CFO/COO
Dominik Escher
Founding Partner
Veronica Gambillara
Partner

Sort

17 May 2021|Singapore|Biotechnology

Target: HUMMINGBIRD BIOSCIENCE

Bidder: FRAZIER HEALTHCARE PARTNERS

18 Service Providers

1 Target | 17 Bidder

18 Dealmakers

1 Target | 18 Bidder

£ 88 M

Value

03 May 2022|Switzerland|Online and Social Platforms

Target: ENGIMMUNE THERAPEUTICS AG

Bidder: NOVO HOLDINGS A/S

6 Service Providers

1 Target | 5 Bidder

9 Dealmakers

1 Target | 8 Bidder

£ 12 M

Value

13 Jun 2022|France|Biotechnology

Target: IMCHECK THERAPEUTICS

Bidder: AGENT CAPITAL

16 Service Providers

3 Target | 13 Bidder

17 Dealmakers

3 Target | 14 Bidder

£ 91 M

Value

15 Dec 2022|Denmark|Biotechnology

Target: MINERVAX

Bidder: TRILL IMPACT

4 Service Providers

2 Target | 2 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 61 M

Value

13 Apr 2023|Switzerland|Pharmaceuticals

Target: ALENTIS THERAPEUTICS

Bidder: PUREOS BIOVENTURES

4 Service Providers

2 Target | 2 Bidder

5 Dealmakers

3 Target | 2 Bidder

n/a

Value

11 Oct 2023|Denmark|Biotechnology

Target: MINERVAX

Bidder: EQT LIFE SCIENCES

4 Service Providers

2 Target | 2 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 46 M

Value

09 Jan 2025|Sweden|Biotechnology

Target: ANACARDIO

Bidder: NOVO HOLDINGS A/S

4 Service Providers

1 Target | 3 Bidder

6 Dealmakers

2 Target | 4 Bidder

£ 14 M

Value

03 Mar 2025|United States|Biotechnology

Target: CALLIO THERAPEUTICS

Bidder: OMEGA FUNDS

13 Service Providers

2 Target | 11 Bidder

34 Dealmakers

17 Target | 17 Bidder

£ 148 M

Value

12 Nov 2024|Switzerland|Pharmaceuticals

Target: ALENTIS THERAPEUTICS

Bidder: INNOBIO

8 Service Providers

3 Target | 5 Bidder

10 Dealmakers

5 Target | 5 Bidder

£ 140 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy